基本信息
浏览量:6
职业迁徙
个人简介
Research in the laboratory of Kah Whye Peng, Ph.D., is aimed at developing novel therapeutics based on replication-competent viruses for cancer therapy, focusing on ovarian cancer and multiple myeloma.
Dr. Peng's team is currently working on the oncolytic measles virus (Edmonston strain) and vesicular stomatitis virus (Indiana strain). These viruses are tumor selective and have promising anti-tumor activity.
Dr. Peng's team is currently working on the oncolytic measles virus (Edmonston strain) and vesicular stomatitis virus (Indiana strain). These viruses are tumor selective and have promising anti-tumor activity.
研究兴趣
论文共 238 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal for immunotherapy of cancerno. 3 (2024): e008307-e008307
Karina Krotova, Gopal Naik Nenavath,Nandakumar Packiriswamy,Rianna Vandergaast, Yumeng McDaniel,Melissa Moy, Zachary Larson,Luke Schnebeck, Chia-Hsuan Chin, Kyle Gromer,Kah-Whye Peng,Stephen J. Russell
Cancer Researchno. 6_Supplement (2024): 7239-7239
Cancer researchno. 8_Supplement (2023): CT207-CT207
Evanthia Galanis,Lynn C. Hartmann,William A. Cliby,Harry J. Long,Prema P. Peethambaram,Brigitte A. Barrette,Judith S. Kaur,Paul J. Haluska,Ileana Aderca,Paula J. Zollman,Jeff A. Sloan,Gary Keeney,Pamela J. Atherton,Karl C. Podratz,Sean C. Dowdy,C. Robert Stanhope,Timothy O. Wilson,Mark J. Federspiel,Kah-Whye Peng,Stephen J. Russell
crossref(2023)
crossref(2023)
Journal of Clinical Oncologyno. 16_suppl (2023): 7530-7530
JOURNAL OF CLINICAL ONCOLOGY (2023): TPS657-TPS657
MOLECULAR THERAPYno. 4 (2023): 157-157
引用0浏览0引用
0
0
crossref(2023)
加载更多
作者统计
#Papers: 239
#Citation: 9268
H-Index: 54
G-Index: 92
Sociability: 7
Diversity: 3
Activity: 31
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn